2,3,5,4'-Tetrahydroxystilbene-2-O-[beta]-D-glucoside Promotes Expression of the Longevity Gene Klotho.
Klotho is a longevity gene that was discovered in 1997 which is expressed in various organs and cells, such as renal tubular cells and the brain choroid . The a-klotho protein can be cleaved, secreted, and released into circulation, presenting a hormone-like effect . Klotho as a serum secretory protein is closely related to age. Its serum level is low in the first decade; it then increases and reaches its peak in the 20-40 age groups and thereafter gradually decreases with age . Klotho has many physiological functions, such as regulating calcium and phosphorus levels in vivo, delaying senescence, improving cognition, reducing oxidative stress, and protecting vascular endothelial cells . Klotho gene-deficient mice exhibit phenotypes similar to several human aging characteristics, such as reduced lifespan, sexual dysfunction, emphysema, deafness, skin atrophy, and system dysfunction of the kidneys, bone, marrow, blood, and brain .
2,3,5,4 -Tetrahydroxystilbene-2-O-[beta]-D-glucoside (THSG), a resveratrol analog of glucoside, exhibits many biological and pharmacological activities . Orally administered THSG is mainly distributed in the heart, kidneys, liver, and lungs of rats , and THSG levels in the plasma and tissues of rats range from 0.27 to 185.00 [micro]g/mL . Regarding cytotoxicity, the hepatotoxicity of THSG had not been determined in hepatic cells for a concentration of 400 [micro]mol/L  and in rat livers for 300mg/kg for 60 days . THSG can extend the lifespan of Caenorhabditis elegans . Our previous studies have determined that THSG suppresses aortic [beta]-galactosidase (senescence-associated [micro]-galactosidase [SA-[beta]-gal]) activity, histone H2A histone family member X (yH2AX) phosphorylation, and p53 acetylation in spontaneously hypertensive rats (SHRs). THSG promotes sirtuin 1 (SIRT1) activity [11, 12] and stimulates endothelial nitric oxide synthase (eNOS) gene luciferase reporter activity and eNOS protein expression. These findings demonstrate that THSG can prevent vascular senescence and improve blood flow through the SirT1-eNOS axis, at least in part, in vitro and in vivo . In the present study, we tested whether THSG regulates the expression of klotho in vitro and in vivo and its related function.
2. Materials and Methods
2.1. Cell Culture. Human Embryonic Kidney 293 (HEK293) cells were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM), or NRK-52E renal tubular epithelial cells were cultured in DMEM medium, containing 10% fetal bovine serum. Cells were grown in a 10 cm dish in 37[degrees]C incubator (5% C[O.sub.2]). The medium was changed every other day, and cells were grown to 80%-90% confluence and digested with 0.25% trypsin and subcultured.
2.2. Animals and THSG Administration. Male SHRs and Wistar-Kyoto rats (WKYs) aged 12 weeks were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). The animals were handled in compliance with the Guide for the Care and Use of Laboratory Animals, and the animal experiments in this study were approved by the Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine. The body weight and rat tail blood pressure were measured before group allocation to ensure homogeneity. Rats were housed in cages (3 per cage) at constant humidity (65% [+ or -] 5%) and temperature (24[degrees] C [+ or -] 1[degrees] C) in a 12-hour light-dark cycle, and rats were provided ad libitum access to tap water and food throughout the experiments. SHRs were adapted to the environment for 1 week and then randomly divided into the following 3 groups (8 per group): 12-week-old control group, 30-weekold control group, and THSG treatment group. Rats in the 12-week-old control group were reared for 12 weeks and then dissected. THSG at 50 mg/kg per day was orally administered to rats in the THSG treatment group for 18 weeks. Rats in the 30-week-old control SHR group received equivalent amounts of adjuvant sodium carboxymethyl cellulose. On the last day of treatment, rats were anesthetized by an intraperitoneal injection of pentobarbital at a dose of 40 mg/kg of body weight and dissected, and their organs were isolated. After weighing, the organs were frozen in liquid nitrogen and stored at -80[degrees]C.
2.3. Detection of Luciferase Reporter System. HEK-293 cells were seeded in 24-well plates at a density of 2 x [10.sup.5] cells/well. The cells were cultured overnight and grown to 70%-90% confluence for transfection with plasmids. In each well, 0.8 [micro]g of a pGL3 reporter plasmid containing a klotho promoter (from -1000 to +299) and the firefly luciferase gene and 0.016 [micro]g of a reporter pRL-SV40 plasmid containing the Renilla luciferase gene as a normalization control were transfected and diluted with the FuGENE HD transfection reagent in the Opti-MEM transfection medium. The medium was replaced with normal DMEM 6 h after transfection. After incubation with THSG (purity > 98%, Shanghai Ding Jie Biological Technology Co., Ltd., Shanghai, China) for 16 h, the activity of the luciferase reporter gene was assayed using the dual-luciferase reporter 1000 assay system and detected using a Varioskan Flash microplate spectrophotometer (Thermo Scientific, USA).
2.4. RNA Isolation and Quantitative Polymerase Chain Reaction. Total RNA was extracted from rat tissues or NRK-52E cells by using Invitrogen's TRIzol reagent (Life Technologies, Grand Island, USA) according to the manufacturer's instructions. First-strand cDNA was synthesized using the High Capacity cDNA Reverse Transcription Kit (Life Technologies). The obtained cDNA was mixed with the Maxima SYBR Green qPCR Master Mix (Thermo Scientific, Waltham, MA, USA) and gene-specific primers (Shanghai Generay Biotech, Shanghai, China). The primer sequences are listed in Table 1. Quantitative polymerase chain reaction (qPCR) was performed using the Applied Biosystems 7500 Fast Real-Time PCR System (Thermo Scientific) according to the manufacturer's instructions. The amplification conditions consisted of an initial denaturation step at 95[degrees] C for 15min, followed by 40 cycles of denaturation at 95[degrees]C for 15 s, annealing at 58[degrees]C for 30 s, and elongation at 72[degrees]C for 30 s. The dissociation curves were analyzed to ensure the amplification of a single PCR product. Three independent assays were performed for each primer. The amount of cDNA was calculated for each sample from the standard curve. The relative expression was determined after the normalization of gene expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
2.5. Western Blotting. NRK-52E cells were lysed in ice-cold Radio Immunoprecipitation Assay (RIPA) buffer (50 mmol/L Tris/HCl, pH 8.0; 150 mmol/L NaCl; 2 mmol/L sodium orthovanadate; 1% Nonidet-P40; 1% sodium deoxycholate; 0.1% sodium dodecylsulfate [SDS], 0.1 mmol/L DTT; 0.05 mmol/L PMSF; 0.002 mg/mL aprotimin; and 0.002 mg/mL leupeptin). Lysates were centrifuged at 12000 rpm/min for 10 min at 4[degrees]C. Aliquots of the cell lysate (50 or 100 [micro]g of each sample) were resolved on SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes were blocked in 5% skim milk overnight at 4[degrees]C. The membranes were incubated with primary antibodies for 2h and then with a horseradish peroxidase- (HRP-) conjugated secondary antibody at room temperature for 1 h. The bands were visualized using an ECL Immobilon Western Chemiluminescent HRP substrate (Millipore, Billerica, MA, USA). Quantitative analysis of band density was performed using Quantity One software from Bio-Rad (Hercules, CA, USA). Western blotting was performed in triplicate.
2.6. Immunohistochemical Staining. Formalin-fixed, paraffin-embedded tissue blocks were cut into 6 [micro]m sections, followed by staining. Immunohistochemical staining was performed using mouse anti-8-hydroxydeoxyguanosine (anti-8-OHDG; ab62623, Abcam, Cambridge, UK) and rabbit antiklotho primary antibodies (ab154163, Abcam), with goat anti-mouse (sc-2005, Santa Cruz Biotechnology, California, CA, USA) and goat anti-rabbit (A0208, Beyotime, China) secondary antibodies, and the LSAB 2 System-HRP was used as the Rat Specimens Kit (Dako, Hamburg, Germany). The intensity of immunohistochemical staining was analyzed using an ImageJ analysis system (NIH, Maryland, MD, USA).
2.7. Cell Senescence Model and Senescence Staining. NRK52E cells were grown to 80%-90% confluence and digested with 0.25% trypsin. Cells were seeded in 24-well plates at a density of 5 x [10.sup.5] cells/well. After adherence, cells were stimulated with 100 nmol/L angiotensin II (Ang II) for 4 days, and the medium including Ang II was changed every 24 h. Subsequently, the cells were stained to assess SA-[beta]-gal activity by using the Cellular Senescence Assay Kit (Cell Biolabs, Inc., San Diego, CA, USA). NRK-52E cells were fixed in 1% formaldehyde containing 0.2% glutaraldehyde in phosphate-buffered saline (PBS) for 5 min at room temperature, rinsed with PBS, and incubated with fresh [beta]-galactosidase staining solution (1mg/mL 5-bromo-4-chloro-3-indolyl [beta]-D galactoside, 40 mmol/L citric acid/sodium phosphate [pH 6.0], 5 mmol/L of potassium ferrocyanide, and 150 mmol/L of Mg[Cl.sub.2]) at 37[degrees]C for 4h or overnight. After staining, the working fluid was discarded, and samples were washed 2 times with PBS. Aging cells were imaged and counted under an optical microscope.
2.8. Determination of Serum Malondialdehyde. Serum malondialdehyde (MDA) levels were measured using a kit from the Nanjing Institute of Biological Engineering (Nanjing, China) in accordance with the procedure specified by the manufacturer. After the appropriate sample and the reagent were added and mixed thoroughly, a small hole was pricked in the lids of centrifuge tubes by using a needle, and samples were heated to 95[degrees]C in a water bath for 80 min. Samples were removed from the water bath, cooled under running water, and centrifuged at 4000 rpm/min for 10 min. A 200 ^L aliquot of the supernatant was seeded into a 96-well plate, and the optical density (OD) of each well was detected at a wavelength of 532 nm by using the SpectraMax 190 Absorbance Microplate Reader (Molecular Devices Corporation, Sunnyvale, CA, USA). Serum MDA levels (nmoL/mL) were calculated as follows: (sample OD value--blank OD value)/(standard OD value--blank OD value) x standard concentration (10 nmoL/mL) x sample dilution before testing.
2.9. Glutathione Peroxidase Activity Assay. Serum glutathione peroxidase (GSH-Px) activity was measured using a kit from the Nanjing Institute of Biological Engineering (Nanjing, China) in accordance with the procedure specified by the manufacturer. The appropriate sample and the reagent were added and mixed thoroughly to facilitate the enzyme-catalyzed reaction. Samples were centrifuged at 4000 rpm/min for 10 min. A 0.1 mL aliquot of the supernatant was added to another test tube. For the color reaction, the chromogenic agent was added and mixed thoroughly. After standing at room temperature for 15 min, the OD of each well was detected at a wavelength of 520 nm by using a Microplate Reader. Serum glutathione peroxidase (GSH-Px) activity was calculated as follows: (control OD value--sample OD value)/(standard OD value--blank OD value) x standard concentration (20 [micro]moL/mL) x sample dilution (6 times) x sample dilution before testing.
2.10. Alkaline Phosphatase Activity Assay. Serum alkaline phosphatase activity was measured using a kit from the Nanjing Institute of Biological Engineering (Nanjing, China) in accordance with the procedure specified by the manufacturer. The appropriate sample and the reagent were added, mixed thoroughly, and incubated in a water bath at 37[degrees]C for 15 min. Finally, the chromogenic agent was added to each well, gently shaken, and mixed thoroughly, and the OD of each well was determined at a wavelength of 520 nm. Serum alkaline phosphatase activity (Guinness units/100 mL) was calculated as follows: (sample OD value--blank OD)/(standard OD value --blank OD value) x standard concentration (0.1 mg/mL) x 100 mL x sample dilution before testing.
2.11. Determination of Serum Calcium and Phosphorus. The rat serum was mixed thoroughly with 0.4 mL of the protein precipitating agent, centrifuged at 3500 rpm/min for 10 min, and placed in an ice bath until use. Serum calcium and phosphorus levels were measured using a kit from the Nanjing Institute of Biological Engineering (Nanjing, China) in accordance with the procedure specified by the manufacturer. Serum calcium and phosphorus levels were measured through the methyl thymol blue method and the molybdenum blue method, respectively. The OD of each well was determined at a wavelength of 610 nm (calcium) or 660 nm (phosphorus) by using a Microplate Reader. Serum calcium and phosphorus levels were calculated as follows: serum calcium or phosphorus level (mmol/L) = (sample OD value--blank OD value)/(standard OD value--blank OD value) x standard concentration (1 mmol/L) x sample dilution before testing.
2.12. Determination of Bone Mineral Density, Mineral Salt, and Strength. After removing the muscles and ligaments attached to the femur and keeping the femur clean and dry, the bone mineral density and mineral salt content of the left femur of the rats were determined using Lunar DPX-L Dual Energy X-ray Absorptiometry Equipment (General Electric, New York, USA). Alternatively, the femoral bearing strength or the maximum transverse bearing strength of bone fracture or the fractured right femur of rats was measured using a bone strength measuring device (Jinan Yi Yan Technology Development Co., Ltd., Jinan City, China).
2.13. Statistical Analyses. The results are presented as means [+ or -] SEM. For parametric data, comparisons among treatment groups were performed using analysis of variance, followed by post hoc tests. All analyses were performed using SPSS (SPSS, Inc., Northampton, MA, USA). P < 0.05 was considered statistically significant.
3.1. THSG Regulated Klotho Expression and Improved Angiotensin II-Induced Cell Senescence In Vitro. To observe the effects of THSG on klotho gene expression, we constructed a pGL3 basic plasmid containing a human klotho promoter (from -1000 to +299) and the firefly luciferase gene, which was transfected into HEK-293 cells. The cells were treated with different concentrations of THSG ([10.sup.-6]-[10.sup.-4] mol/L) for 16 h. The luciferase reporter activity of the klotho gene was determined to be increased in a dose-dependent manner (Figure 1), with [EC.sub.50] of 21 [micro]mol/L.
Renal tubular epithelial cells are one of the main cells with klotho expression. We studied the effect of THSG on klotho expression in NRK-52E rat renal tubular epithelial cells. Klotho mRNA expression was suppressed after cells were stimulated with 100 nmol/L Ang II for 6 or 24 h (Figure 2). However, treatment of cells simultaneously with THSG reversed Ang II-induced inhibition of klotho mRNA expression (Figure 2). Furthermore, after cells were stimulated with Ang II for 24 h, klotho protein expression was reduced, and THSG reversed this trend (Figure 3). In addition, THSG reversed the Ang II-induced inhibition of the protein expression of forkhead box O1 (FOXO1), another aging-related gene. However, p53 protein expression remained unaffected (Figure 3).
Furthermore, long-term stimulation of cultured cells with Ang II (4 days) resulted in the senescence of NRK-52E renal tubular epithelial cells, with nearly 50% of the cell population comprising aging cells (Figure 4). However, THSG treatment significantly reduced the proportion of aging cells, and more than 20% of the cell population comprised aging cells (Figure 4).
3.2. THSG Regulated Klotho Expression and Enhanced Antioxidant Capacity and Bone Strength In Vivo. No significant difference was observed in the blood pressure, the body weight growth trend, and the ratios of organ weight/body weight between 30-week-old SHRs and THSG-treated rats (data not shown).
Klotho mRNA expression was detected in the heart, liver, spleen, renal medulla, renal cortex, adrenal gland, cerebral cortex, hippocampus, bladder, testis, and prostate of30-weekold SHRs, and klotho expression was significantly reduced in the cerebral cortex, hippocampus, testis, and renal medulla compared with 12-week-old SHRs (each n = 8; P < 0.01; Figure 5). THSG administration for 18 weeks increased klotho mRNA expression in the cerebral cortex, hippocampus, testis, and renal medulla of 30-week-old SHRs (each n = 8; P < 0.01; Figure 5). Similar to the aforementioned results determined using qPCR, tissue immunostaining revealed that klotho expression was lower in 30-week-old SHRs than in 30-week-old WKY rats. Furthermore, THSG administration restored klotho expression in the brain, testes, and renal medulla (Figure 6).
THSG increased the blood antioxidant capacity, reduced MDA levels, and increased serum GSH-Px activity (each n = 8, compared with 30-week-old SHRs; P < 0.01; Figure 7). The level of 8-OHDG, a marker of oxidized nucleosides in DNA, was higher in the tissue sections of the brain, testes, and renal medulla of 30-week-old SHRs than in 30-week-old WKY rats. THSG reduced the upward trend of the 8-OHDG level (Figure 8). THSG also reversed the downward trend in serum calcium in SHRs (n = 8, compared with 30-week-old SHRs; P < 0.05; Table 2). Although no significant change was observed in femoral mineral density and bone mineral content in each group of SHRs, femoral bearing strength increased in the THSG treatment group (n = 8, compared with 30-week-old SHRs; P < 0.05; Table 2). In addition, although there were no statistically significant differences, THSG was found to have a tendency to increase creatinine clearance and decrease urinary protein excretion (data not shown).
4.1. Hypertension and Angiotensin II Inhibited Klotho Expression and the Effect of THSG. This study demonstrated that Ang II stimulation and hypertension inhibited klotho expression (Figures 2, 3, and 5). One study reported that Ang II plays a role in inhibiting klotho expression , which is consistent with our findings. Ang II is a crucial inducer of inflammation and oxidative stress, and it can activate NF-[kappa]B transcription activity [14-16] and mitochondrial superoxide [17-19] in different cell types. Moreover, NF-[kappa]B activation and reactive oxidative stress downregulate klotho expression [20-22]. Long-term hypertension is a cardiovascular disease that causes stroke, cardiac hypertrophy, renal failure, and organ fibrosis complications. Various animal models of human hypertension, SHRs, deoxycorticosterone acetate-salt hypertensive rats, and 5/6 nephrectomized rats indicate that sustained circulatory stress inhibits klotho expression . Similarly, hypertensive rats also exhibit low-grade inflammation and harbor high-degree oxidative stress products and present enhanced superoxide production [24-26] and NF-[kappa]B activation [27, 28]. In the present study, THSG could reverse the inhibitory effect of Ang II and hypertension on klotho expression (Figures 2, 3, and 5). Additionally, THSG-induced klotho expression appeared to be direct and dose-dependent in the luciferase reporter test (Figure 1). Although the mechanism by which THSG directly regulates the expression of klotho remains unclear, many studies have indicated that THSG can inhibit oxidative stress and NF-kB activation [29-32].
4.2. Impact of Improved Klotho Expression in the Brain, Kidneys, and Testis. Analysis of klotho mRNA expression in many tissues revealed that mRNA expression was decreased in the brain, testis, and renal medulla of aged SHRs, and the decrease was reversed by THSG (Figures 5 and 6). This finding suggests tissue specificity when THSG regulates the expression of klotho. Augmenting klotho or its effects may enhance cognition and counteract cognitive deficits at different life stages [33, 34], promote the vitality of spermatogenesis , and ameliorate aging-related, Ang II-induced, or glomerulonephritis renal injury [36-38]. Previous studies have shown that THSG can improve learning and memory and promote hippocampal synaptic plasticity in aged rats [39, 40], which may contribute to regulating klotho expression by THSG.
4.3. THSG Antioxidant Effect and Calcium Homeostasis. Our results indicated that THSG could reduce Ang IIinduced NRK-52E renal tubular epithelial cell senescence (Figure 4). Our previous study demonstrated that THSG inhibited the senescence of human and rat vascular endothelial cells and the thoracic aortas in SHRs . Our results also showed that THSG enhanced the antioxidant capacity in vivo, reduced serum MDA and tissue 8-OHDG levels, and increased serum GSH-Px activity (Figures 7 and 8) in aged SHRs. Similar to our results, previous studies have demonstrated that THSG can inhibit oxidative stress in other rat and mouse models [41-43]. In addition, the klotho protein is involved in regulating the antioxidative defense . THSG increased blood calcium levels and the femoral bearing strength (Table 2), indicating that THSG regulates calcium homeostasis by increasing the klotho protein level. Previous studies have reported that klotho can regulate calcium homeostasis [44, 45] and bone metabolism [46, 47]. One cell-level study reported that the protective effect of THSG in osteoblastic MC3T3-E1 cells was mediated by inhibiting the release of bone-resorbing mediators and oxidative damage to cells , reflecting another effect of THSG.
This study demonstrated that THSG regulates klotho expression at the molecular, cellular, and in vivo levels by using the luciferase reporter activity assay, quantitative real-time PCR, and Western blotting. This study also determined that THSG delays cell aging, improves antioxidant capacity, and protects the bone. Because THSG reversed the low expression of klotho in the brain, kidneys, and testis of SHRs, THSG may enhance cognition at different life stages, promote the vitality of spermatogenesis, and ameliorate the renal injury and the antioxidant and bone metabolism that are mediated by klotho.
Abbreviations Ang II: Angiotensin II DMEM: Dulbecco's modified Eagle's medium eNOS: Endothelial nitric oxide synthase FOXO1: Forkhead box O1 GAPDH: Glyceraldehyde-3-phosphate dehydrogenase GSH-Px: Glutathione peroxidase yH2AX: H2A histone family member X HEK-293 cell: Human embryonic kidney 293 cell line HRP: Horseradish Peroxidase MDA: Malondialdehyde NRK-52E: Rat renal tubular epithelial cell line 8-OHDG: 8-Hydroxydeoxyguanosi nep53: Tumor protein p53 qPCR: Real-time quantitative PCR detecting SA-[beta]-gal: [beta]-Galactosidase SHR: Spontaneously hypertensive rat WKY: Wistar-Kyoto rat SIRT1: Sirtuin 1 THSG: 2,3,5,4'-Tetrahydroxystilbene-2-O-[beta]-D-glucoside.
The authors declare that there are no competing interests regarding the publication of this paper.
This work was supported by grants from the Specialized Research Fund for the National Natural Science Foundation of China-Youth Fund (81102532), the Doctoral Program of Higher Education of China (20113107110006), the Innovation Program of Shanghai Municipal Education Commission of China (10ZZ75), and the Shanghai 085 Project of Higher Education Connotation Construction (085ZY1202).
 M. Kuro-o, Y. Matsumura, H. Aizawa et al., "Mutation of the mouse klotho gene leads to a syndrome resembling ageing," Nature, vol. 390, no. 6655, pp. 45-51, 1997.
 T. Shiraki-Iida, H. Aizawa, Y. Matsumura et al., "Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein," FEBS Letters, vol. 424, no. 1-2, pp. 6-10, 1998.
 N.-M. Xiao, Y.-M. Zhang, Q. Zheng, and J. Gu, "Klotho is a serum factor related to human aging," Chinese Medical Journal, vol. 117, no. 5, pp. 742-747, 2004.
 M. Kuro-O, "Klotho in health and disease," Current Opinion in Nephrology and Hypertension, vol. 21, no. 4, pp. 362-368, 2012.
 S. Ling and J. W. Xu, "Biological activities of 2,3,5,4'- tetrahydroxystilbene-2-O-[beta]-D-glucoside in anti-aging and anti-aging-relative diseases," Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4973239,14 pages, 2016.
 Y.-Y. Zhao, L. Zhang, Y.-L. Feng et al., "Pharmacokinetics of 2,3,5,4'-tetrahydroxystilbene-2-O-[beta]-D-glucoside in rat using ultra-performance LC-quadrupole TOF-MS," Journal of Separation Science, vol. 36, no. 5, pp. 863-871, 2013.
 L. Zhang, W.-F. Ma, J. Li et al., "Influence of processing on pharmacokinetic of typical constituents in radix polygoni multiflori after oral administration by LC-ESI-MS/MS," Journal of Ethnopharmacology, vol. 148, no. 1, pp. 246-253, 2013.
 X. Sun, Y. Sun, H. Li, andW. Sun, "Influence of main component of Heshouwu such as emodin, rhein and toluylene glycoside on hepatic cells and hepatoma carcinoma cells," Xian Dai Zhong Xi Yi Jie He Za Zhi, vol. 19, pp. 1315-1317, 2010 (Chinese).
 X. Hu, J. Zhuo, Y. Li, J. Wang, and L. Wang, "Effects of stilbene glucoside from Polygonum Multiflorum Thunb. on hepatic enzymes and serum albumin of rats," Liao Ning Zhong Yi Za Zhi, vol. 38, pp. 988-990, 2011 (Chinese).
 C. Biichter, L. Zhao, S. Havermann et al., "TSG (2,3,5,4'- Tetrahydroxystilbene-2-O-[beta]-D glucoside) from the Chinese herb Polygonum multiflorum increases life span and stress resistance of Caenorhabditis elegans," Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 124357, 12 pages, 2015.
 X. Han, S. Ling, W. Gan, L. Sun, J. Duan, and J.-W. Xu, "2,3,5,4- tetrahydroxystilbene-2-O-[beta]-d-glucoside ameliorates vascular senescence and improves blood flow involving a mechanism of p53 deacetylation," Atherosclerosis, vol. 225, no. 1, pp. 76-82, 2012.
 J. Duan, X. Han, S. Ling et al., "Aortic remodelling is improved by 2,3,5,4'-tetrahydroxystilbene-2-O-[beta]-D-glucoside involving the Smad3 pathway in spontaneously hypertensive rats," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 789027,10 pages, 2015.
 Q. Zhou, S. Lin, R. Tang, P. Veeraragoo, W. Peng, and R. Wu, "Role of fosinopril and valsartan on klotho gene expression induced by angiotensin II in rat renal tubular epithelial cells," Kidney and Blood Pressure Research, vol. 33, no. 3, pp. 186-192, 2010.
 M. Jamaluddin, T. Meng, J. Sun, I. Boldogh, Y. Han, and A. R. Brasier, "Angiotensin II induces nuclear factor (NF)-kB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-[kappa]B activation," Molecular Endocrinology, vol. 14, no. 1, pp. 99-113, 2000.
 D. Gomez-Garre, R. Largo, N. Tejera, J. Fortes, F. Manzarbeitia, and J. Egido, "Activation of NF-[kappa]B in tubular epithelial cells of rats with intense proteinuria role of angiotensin II and endothelin-1," Hypertension, vol. 37, no. 4, pp. 1171-1178, 2001.
 T. Skurk, V. van Harmelen, and H. Hauner, "Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-[kappa]B," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 7, pp. 1199-1203, 2004.
 A. K. Doughan, D. G. Harrison, and S. I. Dikalov, "Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction," Circulation Research, vol. 102, no. 4, pp. 488-496, 2008.
 D.-Y. Lee, F. Wauquier, A. A. Eid et al., "Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species," Journal of Biological Chemistry, vol. 288, no. 40, pp. 28668-28686, 2013.
 S. I. Dikalov, R. R. Nazarewicz, A. Bikineyeva et al., "Nox2induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension," Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 281-294, 2014.
 J. A. Moreno, M. C. Izquierdo, M. D. Sanchez-Nino et al., "The inflammatory cytokines TWEAK and TNF[alpha] reduce renal klotho expression through NF[kappa]B," Journal of the American Society of Nephrology, vol. 22, no. 7, pp. 1315-1325, 2011.
 W. Gao, C. Yuan, J. Zhang et al., "Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury," Clinical Science, vol. 129, no. 12, pp. 1011-1023, 2016.
 H. Shimizu, D. Bolati, A. Adijiang et al., "Indoxyl sulfate downregulates renal expression of Klotho through production of ros and activation of nuclear factor-[kappa]B," American Journal of Nephrology, vol. 33, no. 4, pp. 319-324, 2011.
 H. Aizawa, Y. Saito, T. Nakamura et al., "Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats," Biochemical and Biophysical Research Communications, vol. 249, no. 3, pp. 865-871, 1998.
 G. Zalba, F. J. Beaumont, G. San Jose et al., "Vascular NADH/ NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats," Hypertension, vol. 35, no. 5, pp. 1055-1061, 2000.
 R. Wu, E. Millette, L. Wu, and J. De Champlain, "Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats," Journal of Hypertension, vol. 19, no. 4, pp. 741-748, 2001.
 L. Kopkan and D. S. A. Majid, "Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats," Hypertension, vol. 47, no. 3, pp. 568-572, 2006.
 M. P. Koeners, B. Braam, and J. A. Joles, "Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats," Journal of Hypertension, vol. 29, no. 6, pp. 1160-1166, 2011.
 B. Rodrlguez-Iturbe, A. Ferrebuz, V. Vanegas, Y. Quiroz, S. Mezzano, and N. D. Vaziri, "Early and sustained inhibition of nuclear factor-[kappa]B prevents hypertension in spontaneously hypertensive rats," Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 1, pp. 51-57, 2005.
 T. Wang, J. Gu, P.-F. Wu et al., "Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-[kappa]B pathways and inhibition of intracellular ROS/RNS generation," Free Radical Biology and Medicine, vol. 47, no. 3, pp. 229-240, 2009.
 F. Zhang, Y.-Y. Wang, J. Yang, Y.-F. Lu, J. Liu, and J.-S. Shi, "Tetrahydroxystilbene glucoside attenuates neuroinflammation through the inhibition of microglia activation," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 680545, 8 pages, 2013.
 X. Li, Y. Li, J. Chen et al., "Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation," Neuroscience Letters, vol. 483, no. 1, pp. 1-5, 2010.
 J.-K. Zhang, L. Yang, G.-L. Meng et al., "Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells," European Journal of Pharmacology, vol. 689, no. 1-3, pp. 31-37, 2012.
 D. B. Dubal, J. S. Yokoyama, L. Zhu et al., "Life extension factor klotho enhances cognition," Cell Reports, vol. 7, no. 4, pp. 1065-1076, 2014.
 T. Nagai, K. Yamada, H.-C. Kim et al., "Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress," The FASEB Journal, vol. 17, no. 1, pp. 50-52, 2003.
 A. Kamitani, H. Yamada, M. Kinuta et al., "Distribution of dynamins in testis and their possible relation to spermatogenesis," Biochemical and Biophysical Research Communications, vol. 294, no. 2, pp. 261-267, 2002.
 H. Mitani, N. Ishizaka, T. Aizawa et al., "In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage," Hypertension, vol. 39, no. 4, pp. 838-843, 2002.
 Y. Zeng, P. H. Wang, M. Zhang, and J. R. Du, "Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-[kappa]B signaling pathway in senescence-accelerated mice," Aging Clinical and Experimental Research, vol. 28, no. 1, pp. 69-76, 2016.
 Y. Haruna, N. Kashihara, M. Satoh et al., "Amelioration of progressive renal injury by genetic manipulation of Klotho gene," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2331-2336, 2007.
 R. Wang, Y. Tang, B. Feng et al., "Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats," Neuroscience, vol. 149, no. 4, pp. 739-746, 2007.
 Y. Hou, Q. Yang, L. Zhou et al., "Tetrahydroxystilbene glucoside improves learning and (or) memory ability of aged rats and may be connected to the APP pathway," Canadian Journal of Physiology and Pharmacology, vol. 89, no. 11, pp. 801-809, 2011.
 X. Wang, L. Zhao, T. Han, S. Chen, and J. Wang, "Protective effects of 2,3,5,4/-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice," European Journal of Pharmacology, vol. 578, no. 2-3, pp. 339-348, 2008.
 S.-H. Zhang, W.-Q. Wang, and J.-L. Wang, "Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo," Acta Pharmacologica Sinica, vol. 30, no. 11, pp. 1479-1487, 2009.
 M.-J. Chang, J.-H. Xiao, Y. Wang, Y.-L. Yan, J. Yang, and J.-L. Wang, "2, 3, 5, 4'-tetrahydroxystilbene-2-O-Beta-D-glucoside improves gastrointestinal motility disorders in STZ-induced diabetic mice," PLoS ONE, vol. 7, no. 12, article e50291, 2012.
 A. Imura, Y. Tsuji, M. Murata et al., "a-Klotho as a regulator of calcium homeostasis," Science, vol. 316, no. 5831, pp. 1615-1618, 2007.
 R. T. Alexander, T. E. Woudenberg-Vrenken, J. Buurman et al., "Klotho prevents renal calcium loss," Journal of the American Society of Nephrology, vol. 20, no. 11, pp. 2371-2379, 2009.
 T. Yamashita, A. Nifuji, K. Furuya, Y. Nabeshima, and M. Noda, "Elongation of the epiphyseal trabecular bone in transgenic mice carrying a klotho gene locus mutation that leads to a syndrome resembling aging," Journal of Endocrinology, vol. 159, no. 1, pp. 1-8, 1998.
 T. Yamashita, H. Yoshitake, K. Tsuji, N. Kawaguchi, Y.-I. Nabeshima, and M. Noda, "Retardation in bone resorption after bone marrow ablation in klotho mutant mice," Endocrinology, vol. 141, no. 1, pp. 438-445, 2000.
Shuang Ling, Ju Duan, Rongzhen Ni, and Jin-Wen Xu
Institute of Interdisciplinary Research Complex, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Correspondence should be addressed to Jin-Wen Xu; email@example.com
Received 21 May 2016; Accepted 13 October 2016
Academic Editor: Nageswara Madamanchi
Caption: Figure 1: Effect of THSG on the luciferase reporter activity of the klotho gene. HEK-293 cells that were transiently transfected with luciferase reporter plasmids driven by a human klotho promoter (from -1000 to +299) and reporter pRL-SV40 plasmid containing the Renilla luciferase gene as normalization were stimulated with the indicated doses of THSG for 16 h. Cells were lysed and analyzed for luciferase activity (n = 3). Data are expressed as mean [+ or -] SD. * P < 0.05 versus control empty plasmid, and ** P < 0.01 versus control empty plasmid.
Caption: Figure 2: THSG reversed the decrease in klotho mRNA expression mediated by Ang II in NRK-52E rat renal tubular epithelial cells in vitro. Cells were stimulated with or without Ang II (100 nmol/L) for 6 or 24 h and were treated with or without THSG for 6 or 24 h. Klotho mRNA expression was measured using the Maxima SYBR Green qPCR Master Mix. Data are normalized to GAPDH mRNA expression levels (n = 3 per group). Data are expressed as mean [+ or -] SD. * P < 0.05 versus control group; # P < 0.05 versus Ang II-stimulated group.
Caption: Figure 3: THSG reversed the decrease in klotho and FOXO1 protein expression mediated by Ang II in NRK-52E rat renal tubular epithelial cells in vitro. Cells were stimulated with or without Ang II (100 nmol/L) for 24 h and treated with or without THSG for 24 h. The expression of proteins was detected using Western blotting, and relative densities were normalized to GAPDH expression levels (each group n = 3). Data are expressed as mean [+ or -] SD. * P < 0.05 versus control group; # P < 0.05 versus Ang II-stimulated group.
Caption: Figure 4: THSG inhibited the Ang II-induced senescence of NRK-52E rat renal tubular epithelial cells. Cells were stimulated with or without Ang II (100 nmol/L) for 4 days and treated with or without THSG for 4 days. Subsequently, cells were stained using a [beta]-galactosidase senescence assay kit. More than 200 cells were counted in each sample, and the proportion of senescent cells was calculated (n = 3 per group). Data are expressed as mean [+ or -] SD. * P < 0.05 versus control group; # P < 0.05 versus Ang II-stimulated group.
Caption: Figure 5: Effect of THSG on klotho expression in SHRs. Total RNA was extracted from the rat cerebral cortex, hippocampus, testis, and renal medulla by using Invitrogen's TRIzol reagent. Klotho mRNA expression was measured using the Maxima SYBR Green qPCR Master Mix. Data were normalized to GAPDH mRNA expression levels (each group n = 8). Data are expressed as mean [+ or -] SD; * P < 0.05.
Caption: Figure 6: Klotho expression in the brain, testis, and renal medulla. Immunohistochemical staining for klotho was performed on tissues from 30-week-old WKY rats, 30-week-old SHRs, and SHRs that were treated with THSG. The values in the bar graphs represent the means [+ or -] SD; n = 3. ** P < 0.01 versus the WKY group; ## P < 0.01 versus the SHR group.
Caption: Figure 7: Antioxidant capacity of THSG in SHR sera. Sera were obtained from 12-week-old and 30-week-old SHRs and 30- week-old SHRs that were treated with THSG (n = 8 per group). (a) Lipid-peroxidation MDA and (b) GSH-Px activity were determined in accordance with the procedures of the kit manufacturer. Data are expressed as mean [+ or -] SD; * P < 0.01.
Caption: Figure 8: 8-OHDG levels in the brain, testis, and renal medulla. Immunohistochemical staining for 8-OHDG was performed on tissues from 30-week-old WKY rats, 30-week-old SHRs, and SHRs that were treated with THSG. The values in the bar graphs represent the means [+ or -] SD; n = 3. ** P < 0.01 versus the WKY group; ## P < 0.01 versus the SHR group.
Table 1: Primer sequences of target genes and annealing temperature. Gene Primer sequences Annealing temperature Klotho (138 bp) Sense: 5'-ACTTTCTTCTGCCCTATTT- 58[degrees]C CACG-3' Antisense: 5'-CCAGGTAATC- GTTGTATTTTATCGG-3' GAPDH (192 bp) Sense: 5'-GATCCCGCTAACATCAAATG-3' 58[degrees]C Antisense: 5'-GAGGGAGTTGTCATATTT- CTC-3' Table 2: Effect of Polygonum stilbene glucoside on serum calcium and phosphorus levels and alkaline phosphatase activity and bone strength (x [+ or -] S). Serum Serum Groups calcium phosphorus (mmol/L) (mmol/L) SHR (12 w) 2.18 [+ or -] 0.14 0.83 [+ or -] 0.27 SHR (30 w) 1.90 [+ or -] 0.17 * 0.51 [+ or -] 0.24 * SHR (30 w) + THSG 2.11 [+ or -] 0.16 * 0.46 [+ or -] 0.12 Alkaline Femur Groups phosphatase BMD (IU/L) (g/[cm.sup.2]) SHR (12 w) 74.1 [+ or -] 12.4 0.167 [+ or -] 0.019 SHR (30 w) 73.9 [+ or -] 29.9 0.219 [+ or -] 0.013 * SHR (30 w) + THSG 65.2 [+ or -] 17.6 0.228 [+ or -] 0.014 Bone Femur bearing Groups mineral content strength (g/[cm.sup.2]) (kg) SHR (12 w) 0.475 [+ or -] 0.044 10.60 [+ or -] 2.03 SHR (30 w) 0.685 [+ or -] 0.098 * 12.79 [+ or -] 1.21 * SHR (30 w) + THSG 0.640 [+ or -] 0.075 14.19 [+ or -] 1.38 * * Compared with 12-week-old SHRs, P < 0.05. (#) Compared with 30- week-old SHRs, P < 0.05
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Ling, Shuang; Duan, Ju; Ni, Rongzhen; Xu, Jin-Wen|
|Publication:||Oxidative Medicine and Cellular Longevity|
|Date:||Jan 1, 2016|
|Previous Article:||Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice.|
|Next Article:||Lycopene Ameliorates Transplant Arteriosclerosis in Vascular Allograft Transplantation by Regulating the NO/cGMP Pathways and Rho-Associated Kinases...|